SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Spine-Tech (SPYN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael Anthony who wrote (143)6/20/1997 10:39:00 AM
From: .com   of 242
 
Now up 3 3/8, volume over 650,000. See story below from yesterday.

Dow Jones Newswires -- June 19, 1997
Spine-Tech -2: Co. Sees Great Potential In
Asia

AP-Dow Jones News Service

MINNEAPOLIS -- Spine-Tech Inc. (SPYN) said it's comfortable with
analysts' consensus earnings estimates of 14 cents a share for the second
quarter and 60 cents for the full year.

Speaking at a Piper Jaffray investor conference here, Spine-Tech President
and Chief Executive David W. Stassen said the positive earnings and
revenue trends it experienced in the first quarter should continue in the
second quarter.

Spine-Tech posted a loss of 6 cents a share in the year-ago second quarter
and a loss of 19 cents a share in 1996.

Referring to its overseas opportunities, Stassen said Japan and Korea
represent the largest potential.

He said the U.S. market currently accounts for about 90% of the
company's total sales.

Spine-Tech markets spinal devices and instrumentation for the surgical
treatment of degenerative disc disease of the spine.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext